Advanced Functional Materials,
Год журнала:
2024,
Номер
unknown
Опубликована: Июль 8, 2024
Abstract
Inflammatory
infiltration
of
synovial
M1
macrophages,
high
levels
ROS,
and
NO
exacerbate
osteoarthritis
(OA)
progression.
The
PdZn/Co
SA
‐NC
nanozymes,
which
are
highly
ordered
PdZn
intermetallic
nanoparticles
loaded
with
Co
single
atom
N‐doped
carbon‐rich
in
multi‐level
pores,
an
attempt
to
serve
as
SOD
CAT
mimicking
nanozymes
for
OA
therapy
is
designed.
nanozymes'
electron
transfer
dual
active
site
sufficient
exposure
enhances
free
radical
adsorption
lower
reaction
energies,
accelerating
SOD‐like,
CAT‐like,
GPx‐like
catalyzed
reactions,
outperforming
PdZn/NC
alone.
Furthermore,
exhibit
favorable
biocompatibility,
reduce
macrophage
oxidative
stress
OA,
alleviate
hypoxia,
restore
mitochondrial
function,
regulate
energy
metabolism,
increase
antioxidant
factors,
inflammatory
thus
effectively
mitigating
the
progression
OA.
Mechanistically,
downregulate
M1‐type
phenotypic
markers
like
IL‐1β
by
regulating
purine
metabolism.
offer
a
novel
approach
treating
stress‐related
diseases.
Orthopaedic Surgery,
Год журнала:
2024,
Номер
16(3), С. 532 - 550
Опубликована: Янв. 31, 2024
Osteoarthritis
(OA)
is
the
most
common
chronic
degenerative
joint
disease
in
middle‐aged
and
elderly
people,
characterized
by
pain
dysfunction.
Macrophages
are
key
players
OA
pathology,
their
activation
state
has
been
studied
extensively.
Various
studies
have
suggested
that
macrophages
might
respond
to
stimuli
microenvironment
changing
phenotypes
pro‐inflammatory
or
anti‐inflammatory
phenotypes,
which
called
macrophage
polarization.
accumulate
become
polarized
(M1
M2)
many
tissues,
such
as
synovium,
adipose
tissue,
bone
marrow,
mesenchymal
tissues
joints,
while
resident
well
other
stromal
cells,
including
fibroblasts,
chondrocytes,
osteoblasts,
form
function
an
integrated
unit.
In
this
study,
we
focus
exclusively
on
synovial
macrophages,
tissue
osteoclasts,
investigate
roles
development
of
OA.
We
review
recent
findings
related
polarization
OA,
pathogenesis,
molecular
pathways,
therapeutics.
summarize
several
signaling
pathways
reprogramming
NF‐κB,
MAPK,
TGF‐β,
JAK/STAT,
PI3K/Akt/mTOR,
NLRP3.
Of
note,
despite
increasing
availability
treatments
for
osteoarthritis,
like
intra‐articular
injections,
surgery,
cellular
therapy,
demand
more
effective
clinical
therapies
remained
steady.
Therefore,
also
describe
current
prospective
therapeutic
methods
deem
be
a
target,
physical
stimulus,
chemical
compounds,
biological
molecules,
enhance
cartilage
repair
alleviate
progression
Abstract
Osteoarthritis
(OA)
is
a
chronic
inflammatory
disease
characterized
by
cartilage
destruction,
synovitis,
and
osteophyte
formation.
Disease‐modifying
treatments
for
OA
are
currently
lacking.
Because
inflammation
mediated
an
imbalance
of
M1/M2
macrophages
in
the
synovial
cavities
contributes
to
progression,
regulating
M1
M2
polarization
can
be
potential
therapeutic
strategy.
Basing
on
inherent
immune
mechanism
pathological
environment
OA,
immunoglobulin
G‐conjugated
bilirubin/JPH203
self‐assembled
nanoparticle
(IgG/BRJ)
developed,
its
evaluated.
After
intra‐articular
administration,
IgG
conjugation
facilitates
recognition
engulfment
nanoparticles
macrophages.
The
internalized
disassemble
response
increased
oxidative
stress,
released
bilirubin
(BR)
JPH203
scavenge
reactive
oxygen
species
(ROS),
inhibit
nuclear
factor
kappa‐B
pathway,
suppress
activated
mammalian
target
rapamycin
result
repolarization
enhance
M2/M1
ratios.
Suppression
IgG/BRJ
promotes
protection
repair
rat
model,
thereby
improving
outcomes.
This
strategy
opsonization
involving
engulf
carrier‐free
BR/JPH203
therapy
holds
great
intervention
treatment.
ACS Nano,
Год журнала:
2024,
Номер
18(3), С. 2231 - 2249
Опубликована: Янв. 8, 2024
Rheumatoid
arthritis
(RA)
severely
lowers
the
life
quality
by
progressively
destructing
joint
functions
and
eventually
causing
permanent
disability,
representing
a
pressing
public
health
concern.
The
pathogenesis
of
RA
includes
excessive
production
proinflammatory
cytokines
harmful
oxygen-derived
free
radicals,
such
as
nitric
oxide
(NO),
which
constitute
vital
targets
for
precise
diagnosis
effective
treatment
RA.
In
this
study,
we
introduce
an
advanced
nanoagent
that
integrates
microenvironment-activatable
photoacoustic
(PA)
imaging
with
multitarget
synergistic
A
highly
sensitive
organic
probe
NO-tunable
energy
transformation
molecular
geometry
is
developed,
enables
strong
near-infrared
absorption
turn-on
PA
signal,
active
intramolecular
motion
could
further
boost
conversion.
coassembled
inflammation-responsive
prodrug
to
construct
theranostic
nanoagent,
on
macrophage-derived
cell
membrane
natural
tropism
inflammatory
sites
camouflaged
improve
targeting
ability
inflamed
joints.
not
only
sensitively
detect
differentiate
severity
but
also
efficiently
alleviate
symptoms
function.
combination
activatable
probe-mediated
NO
scavenging
on-demand
activation
anti-inflammatory
significantly
inhibits
factors
promotes
macrophage
repolarization
from
M1
M2
phenotype.
This
meticulously
designed
ingeniously
RA-specific
therapy,
rendering
tremendous
promise
intervention
RA-related
diseases.
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 10, 2025
Abstract
The
infiltration
and
excessive
polarization
of
M1
macrophages
contribute
to
the
induction
persistence
low‐grade
inflammation
in
joint‐related
degenerative
diseases
such
as
osteoarthritis
(OA).
lipid
metabolism
dysregulation
promotes
macrophage
by
coordinating
compensatory
pathways
inflammatory
oxidative
stress
responses.
Here,
a
self‐assembling,
licofelone‐loaded
nanoparticle
(termed
LCF‐CSBN),
comprising
chondroitin
sulfate
bilirubin
joined
an
ethylenediamine
linker,
is
developed
selectively
reprogram
activation.
LCF‐CSBN
internalized
via
CD44‐mediated
endocytosis
targets
Golgi
apparatus
accompanied
with
reactive
oxygen
species‐responsive
release
licofelone
(LCF,
dual
inhibitor
arachidonic
acid
metabolism).
effectively
M2
transition
reprogramming
apparatus‐related
sphingolipid
metabolism.
Intra‐articularly
injected
retains
joint
for
up
28
days
accumulates
into
macrophages.
Moreover,
can
attenuate
inflammation,
stress,
cartilage
degeneration
OA
model
rats.
These
findings
indicate
promising
potential
lipid‐metabolism‐reprogramming
targeted
therapy
OA.
Osteoarthritis and Cartilage,
Год журнала:
2023,
Номер
32(2), С. 148 - 158
Опубликована: Ноя. 7, 2023
Great
progress
continues
to
be
made
in
our
understanding
of
the
multiple
facets
osteoarthritis
(OA)
biology.
Here,
we
review
major
advances
this
field
and
towards
therapy
development
over
past
year,
highlighting
a
selection
relevant
published
literature
from
PubMed
search
covering
year
end
April
2022
2023.
The
selected
articles
have
been
arranged
themes.
These
include
1)
molecular
regulation
articular
cartilage
implications
for
OA,
2)
mechanisms
subchondral
bone
remodelling,
3)
role
synovium
inflammation,
4)
age-related
changes
including
matrix
stiffening,
cellular
senescence,
mitochondrial
dysfunction,
metabolic
impaired
autophagy,
5)
peripheral
OA
pain.
Progress
responsible
aspects
biology
is
unravelling
novel
therapeutic
targets
disease
modification.
Cell Death Discovery,
Год журнала:
2023,
Номер
9(1)
Опубликована: Июнь 23, 2023
Abstract
Pathogens
or
danger
signals
trigger
the
immune
response.
Moderate
response
activation
removes
pathogens
and
avoids
excessive
inflammation
tissue
damage.
Histone
demethylases
(KDMs)
regulate
gene
expression
play
essential
roles
in
numerous
physiological
processes
by
removing
methyl
groups
from
lysine
residues
on
target
proteins.
Abnormal
of
KDMs
is
closely
associated
with
pathogenesis
various
inflammatory
diseases
such
as
liver
fibrosis,
lung
injury,
autoimmune
diseases.
Despite
becoming
exciting
targets
for
diagnosing
treating
these
diseases,
role
enzymes
regulation
still
unclear.
Here,
we
review
underlying
mechanisms
through
which
immune-related
pathways
responses.
In
addition,
also
discuss
future
applications
inhibitors
Abstract
The
interplay
between
immune
cells/macrophages
and
fibroblast‐like
synoviocytes
(FLSs)
plays
a
pivotal
role
in
initiating
synovitis;
however,
their
involvement
metabolic
disorders,
including
diabetic
osteoarthritis
(DOA),
is
largely
unknown.
In
this
study,
single‐cell
RNA
sequencing
(scRNA‐seq)
employed
to
investigate
the
synovial
cell
composition
of
DOA.
A
significant
enrichment
activated
macrophages
within
eight
distinct
clusters
found
DOA
synovium.
Moreover,
it
demonstrated
that
increased
glycolysis
FLSs
key
driver
for
patients’
macrophage
infiltration
polarization.
addition,
yes‐associated
protein
1
(YAP1)/thioredoxin‐interacting
(TXNIP)
signaling
axis
play
crucial
regulating
glucose
transporter
(GLUT1)‐dependent
FLSs,
thereby
controlling
expression
series
adhesion
molecules
such
as
intercellular
molecule‐1
(ICAM‐1)
which
may
subsequently
fine‐tune
M1‐polarized
patients
db/db
OA
mice.
For
treatment,
M1
membrane‐camouflaged
Verteporfin
(Vt)‐loaded
PLGA
nanoparticles
(MVPs)
are
developed
ameliorate
progression
by
YAP1/TXNIP
axis,
thus
suppressing
macrophages.
results
provide
several
novel
insights
into
pathogenesis
offer
promising
treatment
approach
Molecular and Cellular Biochemistry,
Год журнала:
2023,
Номер
479(6), С. 1513 - 1524
Опубликована: Июль 24, 2023
Abstract
Osteoarthritis
(OA),
a
prevalent
degenerative
joint
disease,
affects
substantial
global
population.
Despite
the
elusive
etiology
of
OA,
recent
investigations
have
implicated
mitochondrial
dysfunction
as
significant
factor
in
disease
pathogenesis.
Mitochondria,
pivotal
cellular
organelles
accountable
for
energy
production,
exert
essential
roles
metabolism.
Hence,
can
broad-ranging
effects
on
various
processes
OA
development.
This
comprehensive
review
aims
to
provide
an
overview
metabolic
alterations
occurring
and
elucidate
diverse
mechanisms
through
which
contribute
These
encompass
heightened
oxidative
stress
inflammation,
perturbed
chondrocyte
metabolism,
compromised
autophagy.
Furthermore,
this
will
explore
potential
interventions
targeting
metabolism
means
impede
or
decelerate
progression
OA.
In
summary,
offers
understanding
involvement
underscores
prospective
intervention
strategies.
Advanced Materials,
Год журнала:
2024,
Номер
36(48)
Опубликована: Окт. 6, 2024
Rheumatoid
arthritis
(RA)
represents
an
insidious
autoimmune
inflammatory
disorder
that
severely
lowers
the
life
quality
by
progressively
destructing
joint
functions
and
eventually
causing
permanent
disability,
posing
a
serious
public
health
problem.
Here,
advanced
theranostic
probe
is
introduced
integrates
activatable
second
near-infrared
(NIR-II)
fluorescence
imaging
for
precise
RA
diagnosis
with
multi-pronged
treatments.
A
novel
molecular
comprising
long-wavelength
aggregation-induced
emission
unit
manganese
carbonyl
cage
motif
synthesized,
which
enables
NIR-II
activation
concurrently
releasing
therapeutic
carbon
monoxide
(CO)
gas
in
inflamed
microenvironment.
This
self-assembles
into
biocompatible
nanoprobe,
subsequently
conjugated
anti-IL-6R
antibody
to
afford
active-targeting
ability
of
RA.
The
nanoprobe
exhibits
significant
turn-on
signal
at
lesion,
enabling
highly
sensitive
real-time
monitoring.
combination
ROS
scavenging,
on-demand
CO
release,
IL-6
signaling
blockade
results
potent
effect
synergistic
immunomodulation
impact,
significantly
alleviating
symptoms
preventing
destruction.
research
introduces
paradigm
development
high-performance,
strategies
facilitate
detection
enhanced
treatment
RA-related
diseases.